Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study
EntityUAM. Departamento de Medicina Preventiva y Salud Pública y Microbiología
10.1186/1471-2458-11-704BMC Public Health 11 (2011): 704
Funded byThe EURIKA study was funded by AstraZeneca. The study was run by an independent academic steering committee
Subjectscardiovascular disease; control; mortality; risk factors; SCORE; Medicina
Rights© 2011 Guallar et al., licensee BioMed Central Ltd.
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.
Physicians involved in primary prevention are key players in CVD risk control strategies, but the expected reduction in CVD risk that would be obtained if all patients attending primary care had their risk factors controlled according to current guidelines is unknown. The objective of this study was to estimate the excess risk attributable, firstly, to the presence of CVD risk factors and, secondly, to the lack of control of these risk factors in primary prevention care across Europe. Methods Cross-sectional study using data from the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA), which involved primary care and outpatient clinics involved in primary prevention from 12 European countries between May 2009 and January 2010. We enrolled 7,434 patients over 50 years old with at least one cardiovascular risk factor but without CVD and calculated their 10-year risk of CVD death according to the SCORE equation, modified to take diabetes risk into account. Results The average 10-year risk of CVD death in study participants (N = 7,434) was 8.2%. Hypertension, hyperlipidemia, smoking, and diabetes were responsible for 32.7 (95% confidence interval 32.0-33.4), 15.1 (14.8-15.4), 10.4 (9.9-11.0), and 16.4% (15.6-17.2) of CVD risk, respectively. The four risk factors accounted for 57.7% (57.0-58.4) of CVD risk, representing a 10-year excess risk of CVD death of 5.66% (5.47-5.85). Lack of control of hypertension, hyperlipidemia, smoking, and diabetes were responsible for 8.8 (8.3-9.3), 10.6 (10.3-10.9), 10.4 (9.9-11.0), and 3.1% (2.8-3.4) of CVD risk, respectively. Lack of control of the four risk factors accounted for 29.2% (28.5-29.8) of CVD risk, representing a 10-year excess risk of CVD death of 3.12% (2.97-3.27). Conclusions Lack of control of CVD risk factors was responsible for almost 30% of the risk of CVD death among patients participating in the EURIKA Study.
Google Scholar:Guallar, Eliseo - Banegas Banegas, José Ramón - Blasco-Colmenares, Elena - Jiménez, Francisco Javier Gómez - Dallongeville, Jean - Halcox, Julian PJ J - Borghi, Claudio - Massó-González, Elvira L. - Tafalla, Mónica - Perk, Joep - De Backer, Guy G. - Steg, Philippe Gabriel - Rodríguez Artalejo, Fernando
This item appears in the following Collection(s)
Showing items related by title, author, creator and subject.
C-reactive protein levels in patients at cardiovascular risk: EURIKA study
Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study